Tat is produced very early upon infection [13-15] and continue to be expressed under HAART [21-23], is released extracellularly, accumulates in tissues, and exerts effects on both the virus and the immune system [15-25] that make it an optimal candidate for therapeutic immunization and HAART intensification [22,26-28]. Here, TAT is linked to infection.